Linscomb Wealth Inc. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 22,927 shares of the medical research company’s stock, valued at approximately $2,943,000.
Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Agilent Technologies by 1.8% during the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after acquiring an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Agilent Technologies by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after purchasing an additional 115,183 shares during the period. Generation Investment Management LLP lifted its holdings in shares of Agilent Technologies by 15.9% in the second quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Agilent Technologies during the second quarter worth about $395,088,000. Institutional investors own 87.41% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on A shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Bank of America boosted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Barclays upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price for the company in a report on Monday, December 15th. Hsbc Global Res upgraded shares of Agilent Technologies to a “strong-buy” rating in a research note on Tuesday, January 20th. Finally, Citigroup increased their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $164.50.
Agilent Technologies Stock Performance
Shares of A stock opened at $129.75 on Friday. The company has a fifty day moving average price of $140.43 and a two-hundred day moving average price of $134.90. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The stock has a market cap of $36.78 billion, a P/E ratio of 28.39, a P/E/G ratio of 3.86 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.
Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same period in the prior year, the firm earned $1.46 EPS. Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.
Agilent Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s payout ratio is presently 22.32%.
Insiders Place Their Bets
In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This trade represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 16,401 shares of company stock worth $2,468,962. 0.26% of the stock is owned by company insiders.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
